🇺🇸 Bryophyllum in United States

28 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Exposure During Pregnancy — 6 reports (21.43%)
  2. Hypocalcaemia — 4 reports (14.29%)
  3. Lethargy — 4 reports (14.29%)
  4. Agitation — 2 reports (7.14%)
  5. Chorioamniotic Separation — 2 reports (7.14%)
  6. Confusional State — 2 reports (7.14%)
  7. Foetal Exposure During Pregnancy — 2 reports (7.14%)
  8. Hypersensitivity — 2 reports (7.14%)
  9. Maternal Exposure During Pregnancy — 2 reports (7.14%)
  10. Premature Baby — 2 reports (7.14%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Bryophyllum approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bryophyllum in United States?

University of Zurich is the originator. The local marketing authorisation holder may differ — check the official source linked above.